[{"id":"343a06be-f659-4293-a390-cb751242c1d6","acronym":"","url":"https://clinicaltrials.gov/study/NCT04555551","created_at":"2021-01-18T21:46:38.896Z","updated_at":"2024-07-02T16:35:42.170Z","phase":"Phase 1","brief_title":"MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma","source_id_and_acronym":"NCT04555551","lead_sponsor":"Memorial Sloan Kettering Cancer Center","biomarkers":" SDC1","pipe":"","alterations":" ","tags":["SDC1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MCARH109"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 17","initiation":"Initiation: 09/08/2020","start_date":" 09/08/2020","primary_txt":" Primary completion: 08/01/2024","primary_completion_date":" 08/01/2024","study_txt":" Completion: 08/01/2024","study_completion_date":" 08/01/2024","last_update_posted":"2023-07-24"},{"id":"4a700ab9-69ca-4c09-91fb-3f3d10c837b9","acronym":"","url":"https://clinicaltrials.gov/study/NCT05431608","created_at":"2022-06-24T15:56:46.509Z","updated_at":"2024-07-02T16:35:42.972Z","phase":"Phase 1","brief_title":"A Study of MCARH109 and MCARH125 in People With Multiple Myeloma","source_id_and_acronym":"NCT05431608","lead_sponsor":"Memorial Sloan Kettering Cancer Center","biomarkers":" SDC1","pipe":"","alterations":" ","tags":["SDC1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MCARH109 • MCARH125"],"overall_status":"Recruiting","enrollment":" Enrollment 24","initiation":"Initiation: 06/20/2022","start_date":" 06/20/2022","primary_txt":" Primary completion: 06/20/2024","primary_completion_date":" 06/20/2024","study_txt":" Completion: 06/20/2024","study_completion_date":" 06/20/2024","last_update_posted":"2023-07-14"}]